T12	Treatment 321 352	2-CdA (2-chloro-deoxyadenosine)
T16	Population 372 375	two
T17	Treat-Disorder 389 392	MCD
T20	Drug 321 326	2-CdA
T13	Population 397 400	one
T19	Subject 397 400	one
T21	Subject 372 375	two
T22	Treat-Disorder 406 448	unresectable hyaline-vascular type disease
T23	Treatment 321 352	2-CdA (2-chloro-deoxyadenosine)
T24	Drug 321 326	2-CdA
T14	Potential_therapeutic_event 314 317	use
E1	Potential_therapeutic_event:T14 arg:T19
E2	Potential_therapeutic_event:T14 arg:T12 arg2:T21 arg3:T23
R1	has Arg1:T12 Arg2:T24	
R2	has Arg1:T23 Arg2:T20	
R3	has Arg1:T12 Arg2:T17	
R4	has Arg1:T23 Arg2:T22